FR2454808A1 - Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity - Google Patents
Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activityInfo
- Publication number
- FR2454808A1 FR2454808A1 FR7910652A FR7910652A FR2454808A1 FR 2454808 A1 FR2454808 A1 FR 2454808A1 FR 7910652 A FR7910652 A FR 7910652A FR 7910652 A FR7910652 A FR 7910652A FR 2454808 A1 FR2454808 A1 FR 2454808A1
- Authority
- FR
- France
- Prior art keywords
- cerebral
- syn
- eburnane
- homo
- oxime
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Syn and anti forms of E-homo eburnane oximes of formula (I) and their acid addn. salts are new. A mixt. of syn and anti forms of (I) is disclosed in FR 2104959. Their sepn. may be effected by chromatography. Cerebral vasoregulators useful in the treatment of cerebral vasculopathies, and all other disorders caused by change in cerebral circulation. They allow the prevention or treatment of cerebral arteriosclerosis, meningeal or cerebral haemorrages, cerebral insufficiency, cerebro-vascular accidents and cranial trauma.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7910652A FR2454808A1 (en) | 1979-04-26 | 1979-04-26 | Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7910652A FR2454808A1 (en) | 1979-04-26 | 1979-04-26 | Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2454808A1 true FR2454808A1 (en) | 1980-11-21 |
FR2454808B1 FR2454808B1 (en) | 1983-02-18 |
Family
ID=9224795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7910652A Granted FR2454808A1 (en) | 1979-04-26 | 1979-04-26 | Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2454808A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2529551A1 (en) * | 1982-06-30 | 1984-01-06 | Richter Gedeon Vegyeszet | EBURNANE-OXIME DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
US4549020A (en) * | 1982-06-30 | 1985-10-22 | Richter Gedeon Vegyeszeti Gyar Rt. | Eburnane oxime ethers |
US4551462A (en) * | 1982-06-30 | 1985-11-05 | Richter Gedeon Vegyeszeti Gyar Rt. | Eburnane derivatives, process for their preparation and pharmaceutical compositions containing them |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2104959A2 (en) * | 1970-09-10 | 1972-04-28 | Roussel Uclaf | Vincamine process |
-
1979
- 1979-04-26 FR FR7910652A patent/FR2454808A1/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2104959A2 (en) * | 1970-09-10 | 1972-04-28 | Roussel Uclaf | Vincamine process |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2529551A1 (en) * | 1982-06-30 | 1984-01-06 | Richter Gedeon Vegyeszet | EBURNANE-OXIME DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
US4549020A (en) * | 1982-06-30 | 1985-10-22 | Richter Gedeon Vegyeszeti Gyar Rt. | Eburnane oxime ethers |
US4551462A (en) * | 1982-06-30 | 1985-11-05 | Richter Gedeon Vegyeszeti Gyar Rt. | Eburnane derivatives, process for their preparation and pharmaceutical compositions containing them |
Also Published As
Publication number | Publication date |
---|---|
FR2454808B1 (en) | 1983-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68929540T2 (en) | Substituted phenylpyrimidines derivatives, for the treatment or prevention of CNS disorders | |
EP0065542A4 (en) | Compounds suitable for treatment or prophylaxis of cardiac disorders. | |
CA2203836A1 (en) | Use of astaxanthin for retarding and ameliorating central nervous system and eye damage | |
IL55227A (en) | Pharmaceutical compositions comprising(all-z)-5,8,11,14,17-eicosapentaenoic acid or its salts,esters or amides for the treatment and prophylaxis of thromboembolic conditions | |
NZ225274A (en) | Methylene phosphonoalkylphosphinic acid derivatives and pharmaceutical compositions | |
PH17666A (en) | Non-yellowing topical pharmaceutical composition | |
FR2454808A1 (en) | Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity | |
EP0065964A4 (en) | Method for treatment or prophylaxis of cardiac disorders. | |
AU7896781A (en) | Method for treatment or prophylaxis of cardiac disorders | |
EP0383171A3 (en) | 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders | |
ZA817931B (en) | Compounds and method for treatment or prophylaxis of cardiac disorders | |
ES8702910A1 (en) | Benzodiazepines, process for their preparation and their use. | |
ES8502103A1 (en) | Substituted piperazin-1-yl-acetic-acid amides, process for their preparation and their use. | |
Matussek | Clinical and animal experiments concerning the function of brain catecholamines. | |
Weiler et al. | Auditory adaptation: Loudness balancing vs midplane localization. | |
ZA814902B (en) | Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds | |
Yaryura-Tobias et al. | Psychosis and disturbance of glucose metabolism. | |
Doongaji et al. | Pimozide versus chlordiazepoxide in anxiety neurosis. | |
SU1169672A1 (en) | Method of treatment of disturbances of postural equilibrium | |
Rupert et al. | Effects of bidirectional heart rate biofeedback training on the heart rates and anxiety levels of anxious psychiatric patients. | |
Oftedal | Scandinavian EEG Society: Steroid treatment of infantile spasms with hypsarrhythmia. | |
Zielinski et al. | Pavlovian trace conditioning and inhibition of fear in shuttlebox-avoidance behavior | |
Van Mierlo | Open pilot trial of pimozide in patients suffering from psychic stress. | |
DE3172729D1 (en) | Method for treatment or prophylaxis of cardiac disorders | |
Podivinský et al. | Effect of vestibular caloric stimulation of the H-reflex in hemiparetic patients with focal ischemia of the brain. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CA | Change of address | ||
CD | Change of name or company name | ||
TP | Transmission of property |